1
|
Fitzmaurice C, Zinke R, Heraly B, Kahl B. The Role of rituximab for newly diagnosed, refractory or relapsed aggressive B-cell lymphoma in adult patients. Hippokratia 2016. [DOI: 10.1002/14651858.cd009347.pub2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Christina Fitzmaurice
- University of Washington/Fred Hutchinson Cancer Research Center; Hematology-Oncology; 1100 Fairview Ave N - D5-100 PO Box 19024 Seattle Washington State USA 98109-1024
| | - Richard Zinke
- University of Rochester Medical Center; James P. Wilmot Cancer Institute; 601 Elmwood Avenue, Box 704 Rochester, USA NY 14642
| | - Bradley Heraly
- Devision of Hematology, Oncology and Transplantation; 420 Delaware, SE MMC 480 Minneapolis MN USA 55455
| | - Brad Kahl
- University of Wisconsin Hospital and Clinics; Department of Internal Medicine; 600 Highland Ave Madison WI USA 53705
| |
Collapse
|